Regulatory update - Benlysta (belimumab)
Links shared publicly online about this topic.
- 1,112total visits
Regulatory update - Benlysta (belimumab)
gsk.com —
View full resource at gsk.com
Tags: Lupus, Disease and Condition, GlaxoSmithKline
Most Recently Shared on June 7, 2010 at 1:11 pm By:
GSK files MAA 2 EMA 4 Benlysta (belimumab) 4 reducing disease activity in lupus patients receiving standardtherapy http://ow.ly/1V1Fb
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept) - MarketWatch
marketwatch.com — “Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept) - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on April 5, 2012 at 11:54 am By:
RT @JohnCFierce: Sanofi blockbuster contender Zaltrap flunks prostate cancer Ph3; gets priority review for colorectal http://t.co/mB9YTUbF
Spring Has Sprung! Venture Funding up for Biotech | BioWorld
bioworld.com — “BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date on all of the industry's business, science and regulatory news -- mergers and collaborations, FDA hearings and results, breakthroughs in research and much more.” View full resource at bioworld.com
Most Recently Shared on April 4, 2012 at 1:56 pm By:
John Carroll Health Communicator
And BioWorld tracks a 34% increase in biotech venture rounds in the first quarter. http://t.co/FFClahM2
Social Media: A Matter of Survival for Biopharma | BioWorld
bioworld.com — “BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. BioWorld Online will keep you up to date on all of the industry's business, science and regulatory news -- mergers and collaborations, FDA hearings and results, breakthroughs in research and much more.” View full resource at bioworld.com
Most Recently Shared on December 15, 2011 at 2:50 pm By:
Ryo Kubota, MD, PhD Physician, Doctor, Surgeon, and Ophthalmologist
Social media can be ‘truly transformative’ when we listen to & engage with patients: http://t.co/gPFomaGt Interesting article via @BioWorld
Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine
us.gsk.com — “Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine” View full resource at us.gsk.com
Most Recently Shared on December 1, 2011 at 3:46 pm By:
eyeonfda Pharma and Health Lawyer
GSK submits additional info to FDA for candidate meningococcal and Hib combination vaccine http://t.co/7O2I9g7m
Call for inquiry to cope with genomic breakthroughs | Gastroenterology Update
gastroenterologyupdate.com.au — “Urgent changes to Australia's drug regulatory system are needed to cope with genomic discoveries that are 'fracturing' diseases into rarer subtypes.” View full resource at gastroenterologyupdate.com.au
Most Recently Shared on November 23, 2011 at 4:20 am By:
Gastroenterology Upd Gastroenterology and Medical Publisher
Call for inquiry to cope with genomic breakthroughs http://t.co/P2uJdHmH #gastroenterology
OncLive - Health/Medical/Pharmaceuticals - Plainsboro, NJ | Facebook
facebook.com — “OncLive - OncLive covers every angle of your oncology practice, from new technology to treatment advances to important regulatory decisions | Facebook” View full resource at facebook.com
Most Recently Shared on November 5, 2011 at 7:20 pm By:
Should topical anesthetic be used prior to noncoring needle insertion? Answer on our Facebook page http://t.co/E7X6R4GR
Insmed Incorporated Provides Regulatory Update - Drugs.com MedNews
drugs.com — “Insmed Incorporated (Nasdaq CM INSM), a biopharmaceutical company, today announced that the Company has been notified by the U.S. Food and Drug Administration (” View full resource at drugs.com
Most Recently Shared on October 10, 2011 at 9:14 pm By:
Drugs and Devices OW OW Health
Insmed Incorporated Provides Regulatory Update: MONMOUTH JUNCTION, N.J., Oct. 10, 2011 /PRNewswire/ -- I... http://t.co/ZT32A1XU #drug
Millennium Provides Update On SNDA For VELCADE In Relapsed Follicular Lymphoma
medicalnewstoday.com — “Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) announced that it is withdrawing the supplemental new drug application (sNDA) for t” View full resource at medicalnewstoday.com
Most Recently Shared on October 8, 2011 at 8:05 am By:
Millennium Provides Update On SNDA For VELCADE In Relapsed Follicular Lymphoma http://mnt.to/42bh #lymphoma #leukemia
Subscribe to On Our Radar Daily Newsletter | New Hope 360
newhope360.com — “The NewHope360 On Our Radar is a daily newsletter delivering all the knowledge you need, for suppliers, manufacturers and retailers of natural, organic and healthy products • Breaking news • Regulatory and legislative coverage • Industry updates • People, products and ingredients” View full resource at newhope360.com
Most Recently Shared on August 26, 2011 at 1:06 am By:
Robyn O'Brien Health Executive
Grateful for those who were part of tonight's #naturalchat. Stay in touch at www.allergykidsfoundation.org @NewHope360 http://t.co/nOd7SCR
Regulatory Update: GSK and XenoPort submit supplemental New Drug Application to FDA for Horizant™ in postherpetic neuralgia
us.gsk.com — “Regulatory Update: GSK and XenoPort submit supplemental New Drug Application to FDA for Horizant™ in postherpetic neuralgia” View full resource at us.gsk.com
Most Recently Shared on August 10, 2011 at 1:10 pm By:
eyeonfda Pharma and Health Lawyer
GSK and XenoPort submit supplemental NDA to #FDA for Horizant™ in postherpetic #neuralgia http://ow.ly/5ZEGt
Easy Come, Easy Go? ESC To Review Dronedarone's Role in AF Guidelines - Yahoo! News
news.yahoo.com — “Read 'Easy Come, Easy Go? ESC To Review Dronedarone's Role in AF Guidelines' on Yahoo! News. Less than a year after speeding into the European Society of Cardiology's atrial fibrillation guidelines with a class 1 recommendation, the role of dronedarone (Multaq, Sanofi) in the treatment of AF will be reconsidered."The ESC will produce a focused update of the AF Guidelines when the full results of PALLAS have been published and regulatory authorities have revised the labelling for dronedarone” View full resource at news.yahoo.com
Most Recently Shared on August 4, 2011 at 9:40 pm By:
Easy Come, Easy Go? ESC To Review Dronedarone's Role in AF Guidelines: Less than a year after speeding into the... http://yhoo.it/r6eTvb
ESC announces review of Atrial Fibrillation Guidelines
eurekalert.org — “The ESC will produce a focused update of the AF Guidelines when the full results of PALLAS have been published and regulatory authorities have revised the labeling for dronedarone.” View full resource at eurekalert.org
Most Recently Shared on August 4, 2011 at 9:40 pm By:
ESC announces review of Atrial Fibrillation Guidelines: ( European Society of Cardiology ) The ESC will produce ... http://bit.ly/qPHZYH
Pfizer Provides U.S. Regulatory Update on Prevnar 13? for Use in Adults 50 Years and Older 29.07.2011 | Nachricht | finanzen.net
finanzen.net — “Pfizer Provides U.S. Regulatory Update on Prevnar 13? for Use in Adults 50 Years and Older 29.07.2011 | Nachricht | finanzen.net” View full resource at finanzen.net
Most Recently Shared on July 29, 2011 at 7:40 pm By:
Pfizer Provides U.S. Regulatory Update on Prevnar 13® for Use in Adults 50 Years and Older: Pfizer Inc (NYSE:PFE... http://bit.ly/qUoV1J
GlaxoSmithKline European Regulatory Update on Pandemrix - Drugs.com MedNews
drugs.com — “Issued Thursday 21 July 2011, London UK GlaxoSmithKline (GSK) announced today that the European Medicines Agency s (EMA) Committee for Medicinal Products for Hu” View full resource at drugs.com
Most Recently Shared on July 22, 2011 at 2:04 pm By:
Drugs and Devices OW OW Health
GlaxoSmithKline European Regulatory Update on Pandemrix: Issued: Thursday 21 July 2011, London UK GlaxoSmi... http://bit.ly/nb2qbq #drug
GlaxoSmithKline European regulatory update on Pandemrix™
gsk.com — “GlaxoSmithKline European regulatory update on Pandemrix™” View full resource at gsk.com
Most Recently Shared on July 21, 2011 at 9:09 pm By:
GlaxoSmithKline European regulatory update on Pandemrixâ„¢: GlaxoSmithKline (GSK) announced today that the Europ... http://bit.ly/pZzs2y
Advertisement
